Recognition of early mortality in multiple myeloma by a prediction matrix-Reference-Cited by-同舟云学术

Recognition of early mortality in multiple myeloma by a prediction matrix

Published:2017-07-19 Issue:9 Volume:92 Page:915-923
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Terebelo Howard¹^ORCID,Srinivasan Shankar²,Narang Mohit³,Abonour Rafat⁴,Gasparetto Cristina⁵,Toomey Kathleen⁶,Hardin James W.⁷,Larkins Gail²,Kitali Amani²,Rifkin Robert M.⁸,Shah Jatin J.⁹

Affiliation:

1. Providence Cancer Center; Southfield Michigan

2. Celgene Corporation; Summit New Jersey

3. Maryland Oncology Hematology; Columbia Maryland

4. Indiana University Simon Cancer Center; Indianapolis Indiana

5. Division of Cellular Therapy; Duke University Medical Center; Durham North Carolina

6. Steeplechase Cancer Center; Somerville New Jersey

7. University of South Carolina; Columbia South Carolina

8. US Oncology Research, Rocky Mountain Cancer Centers; Denver Colorado

9. The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

Celgene

Publisher

Wiley

Subject

Hematology

Reference37 articles.

1. Risk factors for early death in patients undergoing treatment for multiple myeloma;Murakami;Ann Hematol.,2001

2. Very early death (< 2 months) in myeloma is associated with advanced age, poor performance status and reduced use of novel agents, while early death within 12 months is associated with high risk features of both the disease and the patient;Kastritis;Blood.,2013

3. Risk stratification in multiple myeloma, part 1: characterization of high-risk disease;Biran;Clin Adv Hematol Oncol.,2013

4. Early mortality in elderly newly diagnosed multiple myeloma patients treate with novel agents: a pooled analysis of two large randomized pahse III trials;Larocca;Haematologica.,2015

5. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party;Augustson;J Clin Oncol,2005

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients;Leukemia;2023-12-07

2. Infecciones en pacientes con diagnóstico reciente de mieloma múltiple: estudio descriptivo unicéntrico de Colombia;CES Medicina;2023-10-27

3. Disparities in Outcomes of Hospitalizations Due to Multiple Myeloma: A Nationwide Comparison;Cureus;2023-10-19

4. Treatment sequences and drug costs from diagnosis to death in multiple myeloma;European Journal of Haematology;2023-10-11

5. Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review;European Journal of Haematology;2023-06-29